Strain | Exposure | Gene | F-value | P-value | Posthoc analysis relative to control |
---|---|---|---|---|---|
C57BL/6 | Acute | Ccl5 | F(4,32) = 5.808 | p < .0012 | UFP |
C57BL/6 | Acute | Cxcl1 | F(4,27) = 8.175 | p < .0001 | UFP |
C57BL/6 | Acute | IL-1β | F(4,32) = 3.404 | p = 0.0199 | UFP + G, FP + G |
C57BL/6 | Acute | IL-6 | F(4,33) = 52.50 | p < .0001 | UFP + G, FP, FP + G (decreased) |
C57BL/6 | Acute | Tgf-β | F(4,33) = 27.02 | p < .0001 | UFP (increased), UFP + G, FP, FP + G (decreased) |
C57BL/6 | Acute | Tnf-α | F(4,33) = 3.909 | p = .0105 | UFP |
C57BL/6 | Acute | Vcam-1 | F(4,32) = 1.205 | ns | none |
ApoE−/− | Acute | Ccl5 | F(4,30) = 0.2138 | ns | none |
ApoE−/− | Acute | Cxcl1 | F(4,30) = 4.377 | p = 0.0066 | none |
ApoE−/− | Acute | IL-1β | F(4,29) = 2.766 | p = 0.05 | UFP, UFP + G |
ApoE−/− | Acute | IL-6 | F(4,31) = 6.408 | p < 0.001 | UFP, UFP + G, FP |
ApoE−/− | Acute | Tgf-β | F(4,31) = 3.978 | p = .0102 | UFP, FP |
ApoE−/− | Acute | Tnf-α | F(4,30) = 4.556 | p = .0054 | UFP, UFP + G, FP, FP + G |
ApoE−/− | Acute | Vcam-1 | F(4,30) = 8.388 | p < .0001 | FP |
C57BL/6 | Chronic | Ccl5 | F(4,19) = 2.967 | p = .0448 | UFP |
C57BL/6 | Chronic | Ccl2 | F(4,18) = 1.398 | ns | none |
C57BL/6 | Chronic | Cxcl1 | F(4,19) = 1.132 | ns | none |
C57BL/6 | Chronic | Et1 | F(4,19) = 1.866 | ns | none |
C57BL/6 | Chronic | IL-6 | F(4,19) = 2.789 | ns (p = .0560) | none |
C57BL/6 | Chronic | Tgf-β | F(4,19) = 2.930 | p = .0452 | UFP + G, FP |
C57BL/6 | Chronic | Vcam-1 | F(4,19) = 2.962 | p = .0465 | UFP + G, FP |
ApoE−/− | Chronic | Ccl5 | F(4,32) = 3.248 | p = .0241 | UFP + G |
ApoE−/− | Chronic | Ccl2 | F(4,29) = 1.422 | ns | none |
ApoE−/− | Chronic | Cxcl1 | F(4,27) = 12.02 | p < .0001 | UFP, UFP + G |
ApoE−/− | Chronic | Et1 | F(4,32) = 1.78 | ns | none |
ApoE−/− | Chronic | IL-6 | F(4,32) = 16.45 | p < .0001 | UFP, UFP + G |
ApoE−/− | Chronic | Tgf-β | F(4,32) = 27.87 | p < .0001 | UFP, UFP + G |
ApoE−/− | Chronic | Vcam-1 | F(4,29) = 3.416 | p = .0209 | none |